首页 > 最新文献

Clinical pharmacy最新文献

英文 中文
The study of the action of the thick extract from the leaves of Corylus avellana on the vascular tissue permeability 榛叶粗提物对维管组织通透性影响的研究
Pub Date : 2015-12-01 DOI: 10.24959/CPHJ.15.1362
L. Maloshtan, G. S. Kalenichenko, O. V. Dorovskyy
Research of the action of the thick extract from the leaves of Corylus avellana on the vascular-tissue permeability of the rats skin has been conducted. Effect of the thick extract from the leaves of Corylus avellana on vascular tissue permeability in rats has been assessed by the time of papules coloring (animal skin at the injection side of flohohen substances) in seconds. We used formalin, histamine, protein, which have different mechanisms of action on capillary permeability. In the group, which has been administrated with the studied extract at its conditional therapeutic dose of 60 mg/kg we have observed the decrease of vascular permeability induced by flohogene substances. It was determined that the most pronounced vessel strengthening effect during the experiment with histamine, where papules coloring has been 1.9 times slower compared with the control group. In comparison with eskuvit the data rates has been approaching to 1. Taking into consideration the mechanism of the action of the applied flohogenes we can suggest that an extract from the leaves of Corylus avellana detects an expressed validity of capillaries permeability and mikrocirculations. Extract showed a moderate effect against the background of formalin and protein inflammation, but this index has exceeded the index of the eskuvit group by 170 seconds against the background of formalin inflammation. The obtained results indicate the presence of capillary resistance activity that is cause for further research of the efficiency of the extract in experimental pathology.
本文研究了榛叶粗提物对大鼠皮肤血管组织通透性的影响。通过测定大鼠皮肤上的斑疹着色时间(以秒为单位),研究了榛叶粗提物对大鼠血管组织通透性的影响。我们使用福尔马林、组胺、蛋白质,它们对毛细血管通透性有不同的作用机制。在以条件治疗剂量60 mg/kg给药的实验组中,我们观察到氟化金物质引起的血管通透性降低。经确定,在使用组胺的实验中,血管强化效果最明显,与对照组相比,丘疹的着色速度慢了1.9倍。与埃斯库维特语相比,数据速率已接近1。考虑到所应用的氟藻基因的作用机制,我们可以建议从榛叶提取物检测到毛细血管通透性和微循环的表达有效性。提取物在福尔马林和蛋白质炎症背景下表现出中等效果,但该指标超过了eskuvit组在福尔马林炎症背景下的170秒。实验结果表明,该提取物具有一定的毛细阻力活性,为进一步研究其在实验病理学上的有效性提供了依据。
{"title":"The study of the action of the thick extract from the leaves of Corylus avellana on the vascular tissue permeability","authors":"L. Maloshtan, G. S. Kalenichenko, O. V. Dorovskyy","doi":"10.24959/CPHJ.15.1362","DOIUrl":"https://doi.org/10.24959/CPHJ.15.1362","url":null,"abstract":"Research of the action of the thick extract from the leaves of Corylus avellana on the vascular-tissue permeability of the rats skin has been conducted. Effect of the thick extract from the leaves of Corylus avellana on vascular tissue permeability in rats has been assessed by the time of papules coloring (animal skin at the injection side of flohohen substances) in seconds. We used formalin, histamine, protein, which have different mechanisms of action on capillary permeability. In the group, which has been administrated with the studied extract at its conditional therapeutic dose of 60 mg/kg we have observed the decrease of vascular permeability induced by flohogene substances. It was determined that the most pronounced vessel strengthening effect during the experiment with histamine, where papules coloring has been 1.9 times slower compared with the control group. In comparison with eskuvit the data rates has been approaching to 1. Taking into consideration the mechanism of the action of the applied flohogenes we can suggest that an extract from the leaves of Corylus avellana detects an expressed validity of capillaries permeability and mikrocirculations. Extract showed a moderate effect against the background of formalin and protein inflammation, but this index has exceeded the index of the eskuvit group by 170 seconds against the background of formalin inflammation. The obtained results indicate the presence of capillary resistance activity that is cause for further research of the efficiency of the extract in experimental pathology.","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"40 1","pages":"26-29"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74526885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The experimental study of anti-inflammatory properties of the drug “Diclocor” “双氯乐”抗炎作用的实验研究
Pub Date : 2015-12-01 DOI: 10.24959/cphj.15.1363
O. S. Popov, S. Shebeko, O. Shevchenko, A. Shalamay
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used groups of medicines. Despite the undeniable clinical effectiveness, their use is associated with the risk of side effects. This fact directs scientific research to searching combinations of NSAIDs with other substances in order to identify compositions which will allow reducing the dose of the NSAID without losing its anti-inflammatory effectiveness. In view of all this, a new combined drug “Diclocor” developed by “Borshchahivskiy CPP” (Ukraine) is of interest. The article presents the results of the experimental study of the anti-inflammatory effect of the combined drug “Diclocor” in comparison with its active monocomponents – diclofenac sodium and quercetin. The alterative stage of inflammation was studied on the model of scarified wounds, the exudative stage – on the model of carrageenin edema, and the proliferative stage – on the model of cotton pellet-induced granuloma. All studies were conducted in rats. The experimental results have shown the superiority of Diclocor in influencing on all three stages of inflammation compared to the reference drugs in the appropriate doses. Diclocor has exhibited the most pronounced effect on the stages of alteration and exudation, and can be described as a promising drug for the treatment of proliferative and destructive inflammatory diseases.
非甾体抗炎药(NSAIDs)是使用最广泛的药物之一。尽管无可否认的临床效果,它们的使用与副作用的风险有关。这一事实指导科学研究寻找非甾体抗炎药与其他物质的组合,以确定既可以减少非甾体抗炎药的剂量又不会失去其抗炎效果的成分。鉴于这一切,“Borshchahivskiy CPP”(乌克兰)开发的一种新的联合药物“Diclocor”引起了人们的兴趣。本文介绍了联合用药双氯芬酸钠和槲皮素与其有效单成分双氯芬酸钠抗炎作用的实验研究结果。以结疤创面为模型,观察炎症的交替期,以卡拉胶性水肿为模型,观察炎症的渗出期,以棉粒性肉芽肿为模型,观察炎症的增殖期。所有的研究都在大鼠身上进行。实验结果表明,在适当的剂量下,与对照药物相比,双氯胺酮对所有三个阶段炎症的影响都具有优势。Diclocor对改变和渗出的阶段表现出最显著的影响,可以被描述为治疗增殖性和破坏性炎症性疾病的有希望的药物。
{"title":"The experimental study of anti-inflammatory properties of the drug “Diclocor”","authors":"O. S. Popov, S. Shebeko, O. Shevchenko, A. Shalamay","doi":"10.24959/cphj.15.1363","DOIUrl":"https://doi.org/10.24959/cphj.15.1363","url":null,"abstract":"Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used groups of medicines. Despite the undeniable clinical effectiveness, their use is associated with the risk of side effects. This fact directs scientific research to searching combinations of NSAIDs with other substances in order to identify compositions which will allow reducing the dose of the NSAID without losing its anti-inflammatory effectiveness. In view of all this, a new combined drug “Diclocor” developed by “Borshchahivskiy CPP” (Ukraine) is of interest. The article presents the results of the experimental study of the anti-inflammatory effect of the combined drug “Diclocor” in comparison with its active monocomponents – diclofenac sodium and quercetin. The alterative stage of inflammation was studied on the model of scarified wounds, the exudative stage – on the model of carrageenin edema, and the proliferative stage – on the model of cotton pellet-induced granuloma. All studies were conducted in rats. The experimental results have shown the superiority of Diclocor in influencing on all three stages of inflammation compared to the reference drugs in the appropriate doses. Diclocor has exhibited the most pronounced effect on the stages of alteration and exudation, and can be described as a promising drug for the treatment of proliferative and destructive inflammatory diseases.","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"30 1","pages":"35-39"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82790948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The study of the influence of a photosensitizer and combined effects of low-intensity laser radiation on the composition of the microflora of the dental plaque 光敏剂与低强度激光联合作用对牙菌斑微生物组成影响的研究
Pub Date : 2014-11-12 DOI: 10.24959/CPHJ.14.1322
N. Filimonova, O. G. Geiderikh, R. Nazarian, K. V. Spiridonova
The effect of low-intensity laser radiation (LILR) on the background of a photosensitizer (ethacridine lactate) on selective elimination of pathogenic and conditionally pathogenic microorganisms has been studied. Taking into account antiseptic properties of ethacridine lactate the maximally possible time of influence of ethacridine lactate as a photosensitizer should be set. It has been found that after the influence of rivanol (ethacridine lactate) within 1.5-3 minutes the bactericidal action on microorganisms is observed. The effect of antiseptic in the interval from 30 to 60 seconds was not accompanied with the expressed quantitative change of the microbial population. The second stage of the research was identification of microorganisms sensitivity to various concentrations of the photosensitizer. As a photosensitizer the aqueous solution of ethacridine lactate in the concentrations of 0.1; 0.05; 0.01% was used. The results obtained allow to conclude that the concentration of 0.1% solution of ethacridine lactate increases the sensitivity of microorganisms to the effects of low-intensity laser radiation. During the experiment the combined impact of the antimicrobial activity of 0.1% solution of ethacridine lactate and blue spectrum laser radiation has been determined; it is manifested by decrease in the number of CFU/ml of the total microflora of the dental plaque. The number of CFU is reduced from 14.3 ± 0.12 . 10 3 /ml up to 2.4 ± 0.3 . 10 2 /ml after exposure (Table 1). Comparing the data of the control (the initial number of the colonies grown) and the experiment (the number of the colonies grown after the photoactivated disinfection) we have found that the antibacterial action of photoactivated disinfection depends directly on duration of exposure. Thus, the effectiveness of combined use of a photosensitizer with LILR is 1.2 times higher than that of ethacridine lactate (the exposure time is 60 seconds), and 2.0 times higher than the antimicrobial effect of the laser blue spectrum (the exposure time is 120 seconds).
本文研究了低强度激光辐射(LILR)在光敏剂(乳酸乙沙吖啶)背景下选择性杀灭致病性微生物和条件致病性微生物的作用。考虑到乳酸乙沙啶的防腐性能,应设定乳酸乙沙啶作为光敏剂的最大可能影响时间。经研究发现,利凡诺(乳酸乙沙吖啶)作用1.5 ~ 3分钟后,对微生物有杀菌作用。在30 ~ 60秒的时间内,抗菌剂的作用不伴有微生物数量的变化。研究的第二阶段是鉴定微生物对不同浓度光敏剂的敏感性。作为光敏剂的乳酸乙沙吖啶水溶液浓度为0.1;0.05;0.01%。结果表明,浓度为0.1%的乳酸乙沙吖啶溶液增加了微生物对低强度激光辐射的敏感性。实验中测定了0.1%乳酸乙沙吖啶溶液与蓝色光谱激光辐射对抗菌活性的联合影响;表现为牙菌斑总菌群的CFU/ml数量减少。CFU数从14.3±0.12减少。10 3 /ml至2.4±0.3。对照(初始菌落生长数)与实验(光活化消毒后菌落生长数)的数据对比发现,光活化消毒的抑菌作用与暴露时间长短直接相关。因此,光敏剂与LILR联合使用的抗菌效果是乳酸乙沙吖啶(曝光时间为60秒)的1.2倍,是激光蓝光谱(曝光时间为120秒)抗菌效果的2.0倍。
{"title":"The study of the influence of a photosensitizer and combined effects of low-intensity laser radiation on the composition of the microflora of the dental plaque","authors":"N. Filimonova, O. G. Geiderikh, R. Nazarian, K. V. Spiridonova","doi":"10.24959/CPHJ.14.1322","DOIUrl":"https://doi.org/10.24959/CPHJ.14.1322","url":null,"abstract":"The effect of low-intensity laser radiation (LILR) on the background of a photosensitizer (ethacridine lactate) on selective elimination of pathogenic and conditionally pathogenic microorganisms has been studied. Taking into account antiseptic properties of ethacridine lactate the maximally possible time of influence of ethacridine lactate as a photosensitizer should be set. It has been found that after the influence of rivanol (ethacridine lactate) within 1.5-3 minutes the bactericidal action on microorganisms is observed. The effect of antiseptic in the interval from 30 to 60 seconds was not accompanied with the expressed quantitative change of the microbial population. The second stage of the research was identification of microorganisms sensitivity to various concentrations of the photosensitizer. As a photosensitizer the aqueous solution of ethacridine lactate in the concentrations of 0.1; 0.05; 0.01% was used. The results obtained allow to conclude that the concentration of 0.1% solution of ethacridine lactate increases the sensitivity of microorganisms to the effects of low-intensity laser radiation. During the experiment the combined impact of the antimicrobial activity of 0.1% solution of ethacridine lactate and blue spectrum laser radiation has been determined; it is manifested by decrease in the number of CFU/ml of the total microflora of the dental plaque. The number of CFU is reduced from 14.3 ± 0.12 . 10 3 /ml up to 2.4 ± 0.3 . 10 2 /ml after exposure (Table 1). Comparing the data of the control (the initial number of the colonies grown) and the experiment (the number of the colonies grown after the photoactivated disinfection) we have found that the antibacterial action of photoactivated disinfection depends directly on duration of exposure. Thus, the effectiveness of combined use of a photosensitizer with LILR is 1.2 times higher than that of ethacridine lactate (the exposure time is 60 seconds), and 2.0 times higher than the antimicrobial effect of the laser blue spectrum (the exposure time is 120 seconds).","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"52 1","pages":"41-44"},"PeriodicalIF":0.0,"publicationDate":"2014-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76799075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recognition of severe cefixime-induced diarrhea. 识别严重头孢克肟引起的腹泻。
Pub Date : 1993-12-01
M A Gales, B J Gales
{"title":"Recognition of severe cefixime-induced diarrhea.","authors":"M A Gales, B J Gales","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"12 12","pages":"881"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19129056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tacrine granted marketing approval for Alzheimer's disease. Tacrine获得阿尔茨海默病上市许可。
Pub Date : 1993-12-01
{"title":"Tacrine granted marketing approval for Alzheimer's disease.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"12 12","pages":"873, 876"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19129054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified Michaelis-Menten equation for estimating unbound-phenytoin concentrations. 估计非结合苯妥英浓度的修正Michaelis-Menten方程。
Pub Date : 1993-12-01
D H Rhoney, W G Leader, M H Chandler
{"title":"Modified Michaelis-Menten equation for estimating unbound-phenytoin concentrations.","authors":"D H Rhoney, W G Leader, M H Chandler","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"12 12","pages":"913-7"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19129061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Criteria for use of epoetin alfa in adult cancer and orthopedic-surgery patients. 成人癌症和骨科手术患者使用促生成素的标准。
Pub Date : 1993-12-01
T A Bennett, J Wingert
{"title":"Criteria for use of epoetin alfa in adult cancer and orthopedic-surgery patients.","authors":"T A Bennett, J Wingert","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"12 12","pages":"925-8"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19129063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics. 应用氨基糖苷药代动力学预测万古霉素药代动力学。
Pub Date : 1993-12-01
L P Welch, W G Leader, M H Chandler
{"title":"Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.","authors":"L P Welch, W G Leader, M H Chandler","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"12 12","pages":"909-13"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19129060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of unbound-quinidine concentration determination after ultrafiltration. 超滤后非结合奎尼丁浓度测定的准确性。
Pub Date : 1993-12-01
C Fan, J E Tisdale, M R Ujhelyi, M S Chow
{"title":"Accuracy of unbound-quinidine concentration determination after ultrafiltration.","authors":"C Fan, J E Tisdale, M R Ujhelyi, M S Chow","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"12 12","pages":"917-21"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19129062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CONTEXT OF A TRANSITION 转换的背景
Pub Date : 1993-12-01 DOI: 10.1093/ajhp/50.12.2616
W. A. Zellmer
{"title":"CONTEXT OF A TRANSITION","authors":"W. A. Zellmer","doi":"10.1093/ajhp/50.12.2616","DOIUrl":"https://doi.org/10.1093/ajhp/50.12.2616","url":null,"abstract":"","PeriodicalId":10498,"journal":{"name":"Clinical pharmacy","volume":"27 1","pages":"923-923"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87090679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Clinical pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1